Abstract
Background:Breast cancer is one of the most common malignancies in women. Genome-wide association studies have identified FGFR2 as a breast cancer susceptibility gene. Common variation in other fibroblast growth factor (FGF) receptors might also modify risk. We tested this hypothesis by studying genotyped single-nucleotide polymorphisms (SNPs) and imputed SNPs in FGFR1, FGFR3, FGFR4 and FGFRL1 in the Breast Cancer Association Consortium.Methods:Data were combined from 49 studies, including 53 835 cases and 50 156 controls, of which 89 050 (46 450 cases and 42 600 controls) were of European ancestry, 12 893 (6269 cases and 6624 controls) of Asian and 2048 (1116 cases and 932 controls) of African ancestry. Associations with risk of breast cancer, overall and by disease sub-type, were assessed using unconditional logistic regression.Results:Little evidence of association with breast cancer risk was observed for SNPs in the FGF receptor genes. The strongest evidence in European women was for rs743682 in FGFR3; the estimated per-allele odds ratio was 1.05 (95% confidence interval=1.02-1.09, P=0.0020), which is substantially lower than that observed for SNPs in FGFR2.Conclusion:Our results suggest that common variants in the other FGF receptors are not associated with risk of breast cancer to the degree observed for FGFR2.
Original language | English |
---|---|
Pages (from-to) | 1088-1100 |
Number of pages | 13 |
Journal | British Journal of Cancer |
Volume | 110 |
Issue number | 4 |
DOIs | |
Publication status | Published - 18 Feb 2014 |
Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: British Journal of Cancer, Vol. 110, No. 4, 18.02.2014, p. 1088-1100.
Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - FGF receptor genes and breast cancer susceptibility
T2 - Results from the Breast Cancer Association Consortium
AU - Agarwal, D.
AU - Pineda, Sandy S
AU - Michailidou, Kyriaki
AU - Herranz, Jesús
AU - Pita, Gabriel
AU - Moreno-Moyano, Laura T.
AU - Alonso, M. Rosario
AU - Dennis, John
AU - Wang, Q.
AU - Bolla, Manjeet K.
AU - Meyer, K. B.
AU - Menéndez-Rodríguez, P.
AU - Hardisson, David
AU - Mendiola, Marta
AU - González-Neira, A.
AU - Lindblom, Annika
AU - Margolin, Sara
AU - Swerdlow, Anthony J
AU - Ashworth, Alan
AU - Orr, N.
AU - Jones, M.
AU - Matsuo, Kosuke
AU - Ito, Hiroshi
AU - Iwata, Hiroji
AU - Kondo, Naomi
AU - kConFab Investigators
AU - Australian Ovarian Cancer Study Group (AOCS)
AU - Hartman, Jacob M
AU - Hui, Mun
AU - Lim, W. Y.
AU - Iau, Philip Tsau-Choong
AU - Sawyer, Edward
AU - Tomlinson, Ian P
AU - Kerin, Michael
AU - Miller, N.
AU - Kang, Deying
AU - Choi, J. Y.
AU - Park, Sarah S
AU - Noh, Dong-Young
AU - Hopper, J. L.
AU - Schmidt, D. F.
AU - Makalic, E.
AU - Southey, M.C.
AU - Teo, S. H.
AU - Yip, C. H.
AU - Sivanandan, Kavitta
AU - Tay, Wan Ting
AU - Brauch, Hiltrud
AU - Brüning, T.
AU - Hamann, Ute
AU - The GENICA Network
AU - Dunning, A. M.
AU - Shah, Ajay M
AU - Andrulis, Irene L
AU - Knight, J. A.
AU - Glendon, Grodon
AU - Tchatchou, Srine
AU - Broeks, Annegien
AU - Rosenberg, E. H.
AU - Van't Veer, Laura J.
AU - Fasching, Peter A.
AU - Renner, Stefan P
AU - Ekici, Arif B
AU - Beckmann, Matthias W.
AU - Shen, Yu-chi
AU - Hsiung, Chia-Ni
AU - Yu, J. C.
AU - Hou, Ming-Feng
AU - Blot, William
AU - Cai, Qian
AU - Wu, A. H.
AU - Tseng, Chiu-Chen
AU - Berg, Christine D
AU - Stram, Daniel O
AU - Cox, A.
AU - Brock, Ian W.
AU - Reed, M. W.R.
AU - Muir, Keith
AU - Lophatananon, Artitaya
AU - Stewart-Brown, Sarah
AU - Siriwanarangsan, Pornthep
AU - Zheng, W H
AU - Deming-Halverson, Sandra
AU - Shrubsole, Matha J.
AU - Long, J.
AU - Shu, Xiao-Ou
AU - Lu, W.
AU - Gao, Y. T.
AU - Zhang, B.
AU - Radice, Paolo
AU - Peterlongo, Paolo
AU - Manoukian, Siranoush
AU - Mariette, Frederique
AU - Sangrajrang, Suleeporn
AU - McKay, J.
AU - Couch, Fergus J
AU - Toland, Amanda E.
AU - Yannoukakos, Drakoulis
AU - Fletcher, Olivia
AU - Johnson, N.
AU - Dos Santos Silva, I.
AU - Peto, Julian
AU - Marme, Frederik
AU - Burwinkel, Barbara
AU - Guénel, P.
AU - Truong, T.
AU - Sanchez, M
AU - Mulot, Claire
AU - Bojesen, Stig E
AU - Nordestgaard, Børge G.
AU - Flyer, H.
AU - Brenner, Hermann
AU - Dieffenbach, Aida K.arina
AU - Arndt, Volker
AU - Stegmaier, Christa
AU - Mannermaa, Arto
AU - Kataja, Vesa
AU - Kosma, Veli-Matti
AU - Hartikainen, Jaana M.
AU - Lambrechts, Diether
AU - Yesilyurt, Betul T.
AU - Floris, Giuseppe
AU - Leunen, Karin
AU - Chang-Claude, Jenny
AU - Rudolph, Anja
AU - Seibold, Petra
AU - Flesch-Janys, Dieter
AU - Wang, X.
AU - Olson, Janet E
AU - Vachon, Celine M
AU - Purrington, Kristen S.
AU - Giles, G.G.
AU - Severi, Gianluca
AU - Baglietto, Laura
AU - Haiman, Christopher A
AU - Henderson, Brian E
AU - Schumacher, Fredrick
AU - Le Marchand, Loic
AU - Simard, Jacques
AU - Dumont, L M
AU - Goldberg, M. S.
AU - Labrèche, F.
AU - Winqvist, Robert
AU - Pylkäs, Katri
AU - Jukkola-Vuorinen, Arja
AU - Grip, Mervi
AU - Devilee, Peter
AU - E M Tollenaar, R. A.
AU - Seynaeve, Caroline
AU - García-Closas, M.
AU - Chanock, Stephen J
AU - Lissowska, Jolanta
AU - Figueroa, Jonine D
AU - Czene, Kamila
AU - Eriksson, M.
AU - Humphreys, Keith
AU - Darabi, Hatef
AU - Hooning, Maartje J
AU - Kriege, Mieke
AU - Collée, J. M.
AU - Tilanus-Linthorst, Madeleine M A
AU - Li, J.
AU - Jakubowska, Anna
AU - Lubinski, Mark J
AU - Jaworska-Bieniek, Katarzyna
AU - Durda, Katarzyna
AU - Nevanlinna, Heli
AU - Muranen, Taru A.
AU - Aittomäki, Kristiina
AU - Blomqvist, Carl
AU - Bogdanova, Natalia
AU - Thilo Dörk, Dörk
AU - Chenevix-Trench, Georgia
AU - Hall, P.
AU - Easton, Douglas F
AU - P Pharoah, P. D.
AU - Arias-Perez, J. I.
AU - Zamora, Pilar
AU - Benítez, J.
AU - Milne, R.L.
PY - 2014/2/18
Y1 - 2014/2/18
N2 - Background:Breast cancer is one of the most common malignancies in women. Genome-wide association studies have identified FGFR2 as a breast cancer susceptibility gene. Common variation in other fibroblast growth factor (FGF) receptors might also modify risk. We tested this hypothesis by studying genotyped single-nucleotide polymorphisms (SNPs) and imputed SNPs in FGFR1, FGFR3, FGFR4 and FGFRL1 in the Breast Cancer Association Consortium.Methods:Data were combined from 49 studies, including 53 835 cases and 50 156 controls, of which 89 050 (46 450 cases and 42 600 controls) were of European ancestry, 12 893 (6269 cases and 6624 controls) of Asian and 2048 (1116 cases and 932 controls) of African ancestry. Associations with risk of breast cancer, overall and by disease sub-type, were assessed using unconditional logistic regression.Results:Little evidence of association with breast cancer risk was observed for SNPs in the FGF receptor genes. The strongest evidence in European women was for rs743682 in FGFR3; the estimated per-allele odds ratio was 1.05 (95% confidence interval=1.02-1.09, P=0.0020), which is substantially lower than that observed for SNPs in FGFR2.Conclusion:Our results suggest that common variants in the other FGF receptors are not associated with risk of breast cancer to the degree observed for FGFR2.
AB - Background:Breast cancer is one of the most common malignancies in women. Genome-wide association studies have identified FGFR2 as a breast cancer susceptibility gene. Common variation in other fibroblast growth factor (FGF) receptors might also modify risk. We tested this hypothesis by studying genotyped single-nucleotide polymorphisms (SNPs) and imputed SNPs in FGFR1, FGFR3, FGFR4 and FGFRL1 in the Breast Cancer Association Consortium.Methods:Data were combined from 49 studies, including 53 835 cases and 50 156 controls, of which 89 050 (46 450 cases and 42 600 controls) were of European ancestry, 12 893 (6269 cases and 6624 controls) of Asian and 2048 (1116 cases and 932 controls) of African ancestry. Associations with risk of breast cancer, overall and by disease sub-type, were assessed using unconditional logistic regression.Results:Little evidence of association with breast cancer risk was observed for SNPs in the FGF receptor genes. The strongest evidence in European women was for rs743682 in FGFR3; the estimated per-allele odds ratio was 1.05 (95% confidence interval=1.02-1.09, P=0.0020), which is substantially lower than that observed for SNPs in FGFR2.Conclusion:Our results suggest that common variants in the other FGF receptors are not associated with risk of breast cancer to the degree observed for FGFR2.
UR - http://www.scopus.com/inward/record.url?scp=84894304619&partnerID=8YFLogxK
U2 - 10.1038/bjc.2013.769
DO - 10.1038/bjc.2013.769
M3 - Article
C2 - 24548884
AN - SCOPUS:84894304619
SN - 0007-0920
VL - 110
SP - 1088
EP - 1100
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 4
ER -